This afternoon, GigCapital2 (GIX.U), the second SPAC effort led by Avi Katz, re-filed their S-1 and amended their terms ahead of their expected IPO pricing next week. Gig2, which is a $130 million TMT focused SPAC, has now added a Right to its Unit and reduced it’s life from 21 months to 18.
Looking more specifically at the changes, Gig2’s new Right is not the standard Right to receive 1/10th of one share, but rather it is 1/20th of one share. However, a right for 1/20th of share on a $130 million deal is rather small. It’s value is only $6.5 million. Will that be enough to satisfy investors?
Well, Gig2 has also reduced the duration on their SPAC by three months, down to 18 months total, to find and close an acquisition. However, they have also added the Crescent Term for this go-around, which adjusts the warrant strike and redemption trigger in the event of the issuance of additional securities in connection with a business combination closing. In light of Constellation Alpha’s recent announcement of their PIPE done at $3.25 per share for their business combination, the Crescent Term feels 100% necessary. It’s not even a sweetener, it just feels mandatory. However, what Gig2 did do to sweeten it is change the threshold at which the Crescent Term kicks in. The $9.20 threshold, which has become customary as of late, has now been given a little extra protective padding with a $9.50 threshold.
All told, Gig2 now has a lot of bells and whistles: one full warrant, a 1/20th right, 18 months, the Crescent Term. And all those bells and whistles mean that investors have been pushing back on this SPAC in light of the fact that the Gig Team still needs to finish Gig1, which is asking for another six months to close their combination with Kaleyra. Investors are not happy that this team is going to have a divided focus. So, in order sell Gig2, this deal needed to be “sweetened-up”. This SPAC will get done, but the real indicator of investor sentiment will be how it trades day-1.
Revised summary of terms below:
At the SPAC of Dawn The market will get more Fed minutes to chew on today ahead of new CPI and PPI readings to finish the week. Meanwhile, the raft of SPACs from the previous cycle that are getting long in the tooth are still reading the tea leaves in terms of how many flexible...
At the SPAC of Dawn The SPAC world is set to get its newest member later today when Launch Two (NASDAQ:LPBBU) begins trading having priced its $200 million IPO overnight. The technology SPAC is the first to IPO this quarter and comes after the newfound SPAC issuance momentum appeared to throttle down slightly in September,...
Launch Two Acquisition Corp. announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “LPBBU”, Tuesday, October 8, 2024. The new SPAC’s primary search focus will be on technology and software infrastructure companies whose products and services target financial services, real estate and...
Oaktree III Life Sciences (NASDAQ:OACCU) has filed for a $175 million SPAC with some of the most aggressively team-friendly terms seen so far in the second half of 2024. The new SPAC’s units contain 1/5 warrants and the trust is not set to be overfunded. Only the warrantless Cantor Equity Partners (NASDAQ:CEP) has IPO’d so...
At the SPAC of Dawn SPACs are set to have a sleepy start to their post-Rosh Hashanah week with no votes on the docket until Wednesday. Three SPACs are to hold extension votes that day and Clover Leaf (OTC:CLOE) will try again to close its combination with Kustom Entertainment after several adjournments on Friday. In...